论文部分内容阅读
目的探讨氧驱雾化布地奈德早期干预治疗婴幼儿喘息的疗效及预后观察、随访结果。方法所有病例均来自肥城市人民医院2008-2009年儿科住院患儿,在保持呼吸道通畅、抗感染,解痉止咳平喘等常规综合治疗同时,治疗组给予布地奈德(普米克令舒)混悬液氧驱雾化治疗;对照组给予传统的地塞米松、α-糜蛋白酶超声雾化治疗。结果治疗组96例婴幼儿喘息患儿中,有效91例,无效5例,对照组90例患儿中有效50例,无效40例。随访喘息再发作次数治疗组明显降低。结论氧驱雾化布地奈德早期干预治疗婴幼儿喘息比传统超声雾化地塞米松等疗效显著,且无严重不良反应发生,值得临床借鉴。
Objective To investigate the curative effect and prognosis of infantile asthma treated with oxygen-driven budesonide early intervention and follow-up results. Methods All cases were from pediatric hospitalized patients in Feicheng People’s Hospital from 2008 to 2009. While maintaining the general comprehensive treatment of airway patency, anti-infection, antispasmodic, cough and asthma, the treatment group was given Budesonide Oxygen atomization suspension treatment; control group given conventional dexamethasone, α-chymotrypsin ultrasound nebulization. Results Among the 96 infants and children with asthma in the treatment group, 91 cases were effective and 5 cases were ineffective. In the 90 cases of control group, 50 cases were effective and 40 cases were ineffective. Follow-up respite episodes were significantly reduced in the treatment group. Conclusion Oxygen inhalation Budesonide early intervention in infants asthma than traditional ultrasonic atomization dexamethasone and other significant effect, and no serious adverse reactions, is worth clinical reference.